Jakob Kaminski
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jakob Kaminski has a total of 288 co-authors. Here are the top co-authors by number of shared publications:
- Andreas Heinz
Department of Psychiatry and Psychotherapy, Technische Universität Dresden
10 shared publications - Florian Schlagenhauf
Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin
8 shared publications - Teresa Katthagen
Charité – Universitätsmedizin Berlin
7 shared publications Caspar Wiegmann
Clinics for Psychiatry and Psychotherapy, Clinics at the Theodor-Wenzel-Werk, Berlin, Deutschland
3 shared publications- Felix Machleid
Department of Psychiatry and Neurosciences, Charité - Universitätsmedizin Berlin, Charitéplatz 1, Berlin, 10117, Germany, 49 30450617297
3 shared publications - Henrik Walter
Charité – Universitätsmedizin Berlin
3 shared publications
Latest Publications
- Open Access
- 17 September 2026
- Published by Center for Open Science in PsyArXiv
Toward Harmonizing Ecological Momentary Assessment (EMA) in Mental Health Research and Services: A Delphi Study on an EMA Core Item Set
Background: Ecological momentary assessment (EMA) captures experience and behavior as they occur in daily life, yielding intensive longitudinal data that are well suited for modeling within- and between-person processes and outcomes. However, heterogeneity in EMA items across studies hampers comparability, data aggregation, and reproducibility.Objective: To establish expert consensus on an EMA core item set, a standardized set of momentary variables from which comparable phenotypic indicators can later be derived. This minimum item set aims to be broadly applicable yet concise enough for use in large-scale research consortia and routine care while maintaining minimal completion time and assessment burden, adopting a nested structure (i.e., minimum core, extended core, add-on modules).Methods: A Delphi study was conducted with support from an international expert panel (J.S., P.K., I.M-G., P.W., M.L.) and 50 invited EMA experts from the German Center for Mental Health (DZPG). Candidate items were derived from prior work, the international expert panel, as well as a narrative review. The items were iteratively refined between Delphi rounds based on aggregated ratings and expert comments. They were assigned to one of three layers – the minimum core, extended core, or add-on modules – according to their degree of generality, the minimum core comprising the most broadly applicable items. A priori consensus was set at ≥75% endorsement. Rating stability and qualitative agreement informed revisions. Experts additionally reported on current methodological EMA practices (e.g., sampling frequency, study duration).Results: The EMA core phenotype was established in three rounds. Participation was n=41 in Round 1 (82%), n=43 in Round 2 (86%), and n=40 in Round 3 (80%). Of 69 initial item candidates, 37 partly revised items remained in the three-tiered structure. The finalized EMA minimum core (7 items) comprises four affect items, one item on social context, and two items on positive and negative events. The EMA extended core includes 5 additional items (total 12) on affect, social context, and activities. Completion time for both the minimum and extended core remains low. More specific items (e.g., self-esteem) are reserved for more specific EMA add-on modules.Conclusions: The consensus-derived DZPG EMA core phenotype provides a consented, ready-to-use item set that balances information yield with minimal assessment burden. By harmonizing EMA assessment across studies, it facilitates comparability, data pooling, and reproducible research while supporting integration into large-scale digital mental health assessment and intervention pipelines. The EMA core will be maintained as a living, versioned measure. Ongoing initiatives include a prospectively specified, multi-study validation program of items, systematic variation of design and assessment procedures (e.g., answering formats), as well as cross-cultural adaptation of the EMA core phenotype.
- 17 September 2026
- Published by Center for Open Science in PsyArXiv
Open AccessToward Harmonizing Ecological Momentary Assessment (EMA) in Mental Health Research and Services: A Delphi Study on an EMA Core Item Set
Background: Ecological momentary assessment (EMA) captures experience and behavior as they occur in daily life, yielding intensive longitudinal data that are well suited for modeling within- and between-person processes and outcomes. However, heterogeneity in EMA items across studies hampers comparability, data aggregation, and reproducibility.Objective: To establish expert consensus on an EMA core item set, a standardized set of momentary variables from which comparable phenotypic indicators can later be derived. This minimum item set aims to be broadly applicable yet concise enough for use in large-scale research consortia and routine care while maintaining minimal completion time and assessment burden, adopting a nested structure (i.e., minimum core, extended core, add-on modules).Methods: A Delphi study was conducted with support from an international expert panel (J.S., P.K., I.M-G., P.W., M.L.) and 50 invited EMA experts from the German Center for Mental Health (DZPG). Candidate items were derived from prior work, the international expert panel, as well as a narrative review. The items were iteratively refined between Delphi rounds based on aggregated ratings and expert comments. They were assigned to one of three layers – the minimum core, extended core, or add-on modules – according to their degree of generality, the minimum core comprising the most broadly applicable items. A priori consensus was set at ≥75% endorsement. Rating stability and qualitative agreement informed revisions. Experts additionally reported on current methodological EMA practices (e.g., sampling frequency, study duration).Results: The EMA core phenotype was established in three rounds. Participation was n=41 in Round 1 (82%), n=43 in Round 2 (86%), and n=40 in Round 3 (80%). Of 69 initial item candidates, 37 partly revised items remained in the three-tiered structure. The finalized EMA minimum core (7 items) comprises four affect items, one item on social context, and two items on positive and negative events. The EMA extended core includes 5 additional items (total 12) on affect, social context, and activities. Completion time for both the minimum and extended core remains low. More specific items (e.g., self-esteem) are reserved for more specific EMA add-on modules.Conclusions: The consensus-derived DZPG EMA core phenotype provides a consented, ready-to-use item set that balances information yield with minimal assessment burden. By harmonizing EMA assessment across studies, it facilitates comparability, data pooling, and reproducible research while supporting integration into large-scale digital mental health assessment and intervention pipelines. The EMA core will be maintained as a living, versioned measure. Ongoing initiatives include a prospectively specified, multi-study validation program of items, systematic variation of design and assessment procedures (e.g., answering formats), as well as cross-cultural adaptation of the EMA core phenotype.
- 19 February 2026
- Published by Georg Thieme Verlag KG in Nervenheilkunde
- Vol. 45 (01/02) , 64-65
Wie Forschung besser werden kann: Mit Patient and Public Invovement (PPI)
Zusammenfassung: Partizipation ist ein Menschenrecht, so steht es in der UN-Behindertenrechtskonvention und wird so vom Bundesministerium für Bildung und Forschung in einem Grundsatzpapier ebenfalls für die Forschung betont. Die Notwendigkeit partizipativer Ansätze – auch in der Psychiatrie – ist klar. Echte Innovation mit gesellschaftlicher Wirkung entsteht erst dann, wenn Betroffene als Ko-Forschende beteiligt werden.
- 19 February 2026
- Published by Georg Thieme Verlag KG in Nervenheilkunde
- Vol. 45 (01/02) , 64-65
Wie Forschung besser werden kann: Mit Patient and Public Invovement (PPI)
Zusammenfassung: Partizipation ist ein Menschenrecht, so steht es in der UN-Behindertenrechtskonvention und wird so vom Bundesministerium für Bildung und Forschung in einem Grundsatzpapier ebenfalls für die Forschung betont. Die Notwendigkeit partizipativer Ansätze – auch in der Psychiatrie – ist klar. Echte Innovation mit gesellschaftlicher Wirkung entsteht erst dann, wenn Betroffene als Ko-Forschende beteiligt werden.
- Open Access
- 28 January 2026
- Published by JMIR Publications Inc. in JMIR Mental Health
- Vol. 13 (1) , e63088
Remote Measurement-Based Care Interventions for Mental Health: Systematic Review and Meta-Analysis
Background: Poor management of mental health conditions leads to reduced adherence to treatment, prolonged illness, unnecessary rehospitalization, and a significant financial burden to the health care system. Recognizing this, ecological momentary assessment (EMA) and remote measurement-based care (RMBC) interventions have emerged as promising strategies to address gaps in current care systems. They provide a convenient means to continuously monitor patient-reported outcomes, thereby informing clinical decision-making and potentially improving outcomes such as psychopathology, relapse, and quality of life. Objective: This systematic review and meta-analysis aims to comprehensively appraise and analyze the existing evidence on the use of EMA and RMBC for people living with mental illness. Methods: The study was conducted according to PRISMA-P (Preferred Reporting Items for Systematic Review and Explanation Meta-Analysis Protocols) guidelines and preregistered with the PROSPERO systematic review registry. A comprehensive search was conducted in 4 online databases using Medical Subject Headings terms related to mental disorders and digital technologies. Studies were included if they included adults with a formally diagnosed mental disorder and measured symptoms using EMA or RMBC. Studies were independently reviewed by subgroups of authors, and data were extracted focusing on symptom-focused or disease-specific outcomes, relapse, recovery-focused outcomes, global functioning, quality of life, and acceptability of the intervention. We performed a descriptive analysis of demographic variables and a meta-analysis of randomized controlled trials (RCTs). Risk of bias was assessed using the Cochrane risk-of-bias tool for randomized trials version 2 (RoB-2). Results: The systematic review included 103 studies, of which 15 used RMBC. Of these, 9 were RCTs that were meta-analyzed. RMBC interventions varied in effectiveness, generally showing small but significant effects on symptom-specific outcomes, with notable effects on mania symptoms and empowerment. The mean adherence rate across studies to all tracking items was 74.5% (SD 13.98; n=38). More prompts per day, but not more items per prompt, were associated with lower adherence. Adverse effects were infrequently reported and included technical problems and psychological distress. Concerns about bias were raised, particularly regarding participants’ awareness of the interventions and potential deviations from the intended protocols. Conclusions: Although RMBC shows growing potential in improving and tailoring psychiatric care to individual needs, the evidence of its clinical effectiveness is still limited. However, we found potential effects on mania symptoms and empowerment. Overall, there were only a few RCTs with formal psychiatric diagnoses to be included in our analyses, and these had moderate risks of bias. Future studies assessing RMBC’s effectiveness and long-term efficacy with larger populations are needed.
- 28 January 2026
- Published by JMIR Publications Inc. in JMIR Mental Health
- Vol. 13 (1) , e63088
Open AccessRemote Measurement-Based Care Interventions for Mental Health: Systematic Review and Meta-Analysis
Background: Poor management of mental health conditions leads to reduced adherence to treatment, prolonged illness, unnecessary rehospitalization, and a significant financial burden to the health care system. Recognizing this, ecological momentary assessment (EMA) and remote measurement-based care (RMBC) interventions have emerged as promising strategies to address gaps in current care systems. They provide a convenient means to continuously monitor patient-reported outcomes, thereby informing clinical decision-making and potentially improving outcomes such as psychopathology, relapse, and quality of life. Objective: This systematic review and meta-analysis aims to comprehensively appraise and analyze the existing evidence on the use of EMA and RMBC for people living with mental illness. Methods: The study was conducted according to PRISMA-P (Preferred Reporting Items for Systematic Review and Explanation Meta-Analysis Protocols) guidelines and preregistered with the PROSPERO systematic review registry. A comprehensive search was conducted in 4 online databases using Medical Subject Headings terms related to mental disorders and digital technologies. Studies were included if they included adults with a formally diagnosed mental disorder and measured symptoms using EMA or RMBC. Studies were independently reviewed by subgroups of authors, and data were extracted focusing on symptom-focused or disease-specific outcomes, relapse, recovery-focused outcomes, global functioning, quality of life, and acceptability of the intervention. We performed a descriptive analysis of demographic variables and a meta-analysis of randomized controlled trials (RCTs). Risk of bias was assessed using the Cochrane risk-of-bias tool for randomized trials version 2 (RoB-2). Results: The systematic review included 103 studies, of which 15 used RMBC. Of these, 9 were RCTs that were meta-analyzed. RMBC interventions varied in effectiveness, generally showing small but significant effects on symptom-specific outcomes, with notable effects on mania symptoms and empowerment. The mean adherence rate across studies to all tracking items was 74.5% (SD 13.98; n=38). More prompts per day, but not more items per prompt, were associated with lower adherence. Adverse effects were infrequently reported and included technical problems and psychological distress. Concerns about bias were raised, particularly regarding participants’ awareness of the interventions and potential deviations from the intended protocols. Conclusions: Although RMBC shows growing potential in improving and tailoring psychiatric care to individual needs, the evidence of its clinical effectiveness is still limited. However, we found potential effects on mania symptoms and empowerment. Overall, there were only a few RCTs with formal psychiatric diagnoses to be included in our analyses, and these had moderate risks of bias. Future studies assessing RMBC’s effectiveness and long-term efficacy with larger populations are needed.
- Open Access
- 13 August 2025
- Published by Springer Nature in Der Nervenarzt
- Vol. 96 (5) , 432-438
Digitale Gesundheitsanwendungen für depressive Störung in Deutschland
Zusammenfassung: Hintergrund: Digitale Technologien eröffnen neue Möglichkeiten in der Behandlung psychischer Störungen. Insbesondere internet- und mobilbasierte Interventionen (IMIs) haben sich als wirksame, kosteneffiziente und zeit- und ortsunabhängige Ansätze erwiesen, die zur Verbesserung der Versorgung von Menschen mit psychischen Störungen beitragen können. In Deutschland spielen die in der Regelversorgung von allen gesetzlichen Krankenkassen erstatteten digitalen Gesundheitsanwendungen (DiGAs) eine zunehmende Rolle. Ziel der Arbeit: Ziel dieses Artikels ist es, eine narrative Übersicht zur Evidenzlage und den Herausforderungen von DiGAs für Depression im deutschen Gesundheitswesen zu bieten. Es werden die zugelassenen DiGAs vorgestellt und zentrale Studien und Entwicklungen dargestellt sowie Perspektiven für zukünftige Forschungs- und Versorgungskonzepte aufgezeigt. Material und Methoden: Die Arbeit basiert auf einer narrativen Übersicht relevanter Literatur. Ein besonderer Fokus liegt auf den durch das Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) zugelassenen DiGAs zur Behandlung von Depression und deren Einbettung in die Versorgung sowie die Akzeptanz bei Patient:innen und Behandler:innen. Ergebnisse: Insbesondere internetbasierte kognitive Verhaltenstherapie (iKVT) zeigt eine kleine bis mittlere Effektstärke bei Depressionen, die mit einer Face-to-face-Therapie vergleichbar ist (Hedge’s g = 0,43). In der Evidenz und in der Versorgung scheinen „Guided“- und „Blended-care“-Ansätze Vorteile zu bieten. Gleichzeitig ist die Nutzung von DiGAs im Vergleich zur großen Zahl der Betroffenen gering, was u. a. auf Faktoren wie fehlende Bekanntheit, komplexe Zugangswege und Verordnungsprozesse sowie Datenschutzbedenken zurückzuführen ist. Diskussion: Trotz vielversprechender Evidenz bleibt die Integration von DiGAs in bestehende Versorgungssysteme eine Herausforderung. Zukünftige Forschungsbemühungen sollten auf die Langzeitwirksamkeit, Personalisierung digitaler Lösungen und hybride Versorgungsmodelle abzielen, um Akzeptanz und Inanspruchnahme zu fördern.
- 13 August 2025
- Published by Springer Nature in Der Nervenarzt
- Vol. 96 (5) , 432-438
Open AccessDigitale Gesundheitsanwendungen für depressive Störung in Deutschland
Zusammenfassung: Hintergrund: Digitale Technologien eröffnen neue Möglichkeiten in der Behandlung psychischer Störungen. Insbesondere internet- und mobilbasierte Interventionen (IMIs) haben sich als wirksame, kosteneffiziente und zeit- und ortsunabhängige Ansätze erwiesen, die zur Verbesserung der Versorgung von Menschen mit psychischen Störungen beitragen können. In Deutschland spielen die in der Regelversorgung von allen gesetzlichen Krankenkassen erstatteten digitalen Gesundheitsanwendungen (DiGAs) eine zunehmende Rolle. Ziel der Arbeit: Ziel dieses Artikels ist es, eine narrative Übersicht zur Evidenzlage und den Herausforderungen von DiGAs für Depression im deutschen Gesundheitswesen zu bieten. Es werden die zugelassenen DiGAs vorgestellt und zentrale Studien und Entwicklungen dargestellt sowie Perspektiven für zukünftige Forschungs- und Versorgungskonzepte aufgezeigt. Material und Methoden: Die Arbeit basiert auf einer narrativen Übersicht relevanter Literatur. Ein besonderer Fokus liegt auf den durch das Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) zugelassenen DiGAs zur Behandlung von Depression und deren Einbettung in die Versorgung sowie die Akzeptanz bei Patient:innen und Behandler:innen. Ergebnisse: Insbesondere internetbasierte kognitive Verhaltenstherapie (iKVT) zeigt eine kleine bis mittlere Effektstärke bei Depressionen, die mit einer Face-to-face-Therapie vergleichbar ist (Hedge’s g = 0,43). In der Evidenz und in der Versorgung scheinen „Guided“- und „Blended-care“-Ansätze Vorteile zu bieten. Gleichzeitig ist die Nutzung von DiGAs im Vergleich zur großen Zahl der Betroffenen gering, was u. a. auf Faktoren wie fehlende Bekanntheit, komplexe Zugangswege und Verordnungsprozesse sowie Datenschutzbedenken zurückzuführen ist. Diskussion: Trotz vielversprechender Evidenz bleibt die Integration von DiGAs in bestehende Versorgungssysteme eine Herausforderung. Zukünftige Forschungsbemühungen sollten auf die Langzeitwirksamkeit, Personalisierung digitaler Lösungen und hybride Versorgungsmodelle abzielen, um Akzeptanz und Inanspruchnahme zu fördern.
- Open Access
- 1 May 2025
- Published by SAGE Publications in Digital Health
- Vol. 11
Highly adaptable smartphone-based monitoring for patients with severe mental illness: Feasibility and usability study
Objective: Severe mental illness (SMI) requires continuous treatment. Smartphone-based monitoring enables real-time data collection and offers a way of complementing clinical workflows by creating a bridge between patients and providers. Since their needs often differ, collaborative and highly adaptable tools are warranted. The objective of this study was to evaluate the feasibility of the highly adaptable remote-measurement-based care intervention Recovery Cat for patients with SMI. Specifically, we aimed to assess patient adherence and retention rates of the system as well as patients’ and providers’ perceptions of its usability. Methods: Forty-nine patients were recruited for the 90-day trial and were provided with Recovery Cat a smartphone app designed to collaboratively set up and monitor clinical symptoms and functional parameters. Data were collected through daily self-reports. Feasibility was assessed by the dropout rate and user engagement, while user-friendliness was evaluated by the System Usability Scale (SUS). Results: 29 participants completed the study. The majority were single, unemployed, diagnosed with an affective disorder, had prior psychiatric treatment, and were in continuous outpatient psychiatric care. EMA data were available for 26 participants. 84.61% ( n = 22) had an adherence rate of over 50%. The mean number of days between data entry was 1.48 (sd = 2.02). The SUS indicated a positive user experience with a mean of 82.40 (sd = 11.57). Conclusion: The results suggest that highly adaptable smartphone-based monitoring is feasible for patients with SMI. High adherence rates and positive usability scores indicate that this approach holds promise for enhancing mental health care.
- 1 May 2025
- Published by SAGE Publications in Digital Health
- Vol. 11
Open AccessHighly adaptable smartphone-based monitoring for patients with severe mental illness: Feasibility and usability study
Objective: Severe mental illness (SMI) requires continuous treatment. Smartphone-based monitoring enables real-time data collection and offers a way of complementing clinical workflows by creating a bridge between patients and providers. Since their needs often differ, collaborative and highly adaptable tools are warranted. The objective of this study was to evaluate the feasibility of the highly adaptable remote-measurement-based care intervention Recovery Cat for patients with SMI. Specifically, we aimed to assess patient adherence and retention rates of the system as well as patients’ and providers’ perceptions of its usability. Methods: Forty-nine patients were recruited for the 90-day trial and were provided with Recovery Cat a smartphone app designed to collaboratively set up and monitor clinical symptoms and functional parameters. Data were collected through daily self-reports. Feasibility was assessed by the dropout rate and user engagement, while user-friendliness was evaluated by the System Usability Scale (SUS). Results: 29 participants completed the study. The majority were single, unemployed, diagnosed with an affective disorder, had prior psychiatric treatment, and were in continuous outpatient psychiatric care. EMA data were available for 26 participants. 84.61% ( n = 22) had an adherence rate of over 50%. The mean number of days between data entry was 1.48 (sd = 2.02). The SUS indicated a positive user experience with a mean of 82.40 (sd = 11.57). Conclusion: The results suggest that highly adaptable smartphone-based monitoring is feasible for patients with SMI. High adherence rates and positive usability scores indicate that this approach holds promise for enhancing mental health care.
- Open Access
- 16 February 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (2) , e0297929
Remote measurement based care (RMBC) interventions for mental health—Protocol of a systematic review and meta-analysis
Background: Poor management of mental illnesses is associated with lower treatment adherence, chronification, avoidable re-hospitalisations, and high costs. Remote measurement based care (RMBC) interventions have gained increasing relevance due to its potential in providing a comprehensive and patient-centric approach to mental health management. Objectives: The systematic review and meta-analysis aims to provide a comprehensive overview and analysis of existing evidence on the use of RMBC for patients with mental illness and to examine the effectiveness of RMBC interventions in alleviating disorder-specific symptoms, reducing relapse and improving recovery-oriented outcomes, global functioning, and quality of life. Methods and analysis: Our multidisciplinary research team will develop a comprehensive search strategy, adapted to each electronic database (PubMed, Medline, Embase, and PsychINFO) to be examined systematically. Studies with patients formally diagnosed by the International Classification of Diseases or the Diagnostic and Statistical Manual of Mental Disorders which include assessment of self-reported psychiatric symptoms will be included. Publications will be reviewed by teams of independent researchers. Quality of studies will be assessed using the Cochrane Collaboration’s tool for assessing risk of bias. Outcomes cover symptom-focused or disease-specific outcomes, relapse, recovery-focused outcomes, global functioning, quality of life and acceptability of the intervention. Further data that will be extracted includes study characteristics, target population, intervention, and tracking characteristics. Data will be synthesised qualitatively, summarising findings of the systematic review. Randomised controlled trials (RCTs) will be considered for meta-analysis if data is found comparable in terms of mental illness, study design and outcomes. Cumulative evidence will be evaluated according to the Grading of Recommendations Assessment, Development and Evaluation framework. Trial registration: Trial registration number: PROSPERO CRD42022356176.
- 16 February 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (2) , e0297929
Open AccessRemote measurement based care (RMBC) interventions for mental health—Protocol of a systematic review and meta-analysis
Background: Poor management of mental illnesses is associated with lower treatment adherence, chronification, avoidable re-hospitalisations, and high costs. Remote measurement based care (RMBC) interventions have gained increasing relevance due to its potential in providing a comprehensive and patient-centric approach to mental health management. Objectives: The systematic review and meta-analysis aims to provide a comprehensive overview and analysis of existing evidence on the use of RMBC for patients with mental illness and to examine the effectiveness of RMBC interventions in alleviating disorder-specific symptoms, reducing relapse and improving recovery-oriented outcomes, global functioning, and quality of life. Methods and analysis: Our multidisciplinary research team will develop a comprehensive search strategy, adapted to each electronic database (PubMed, Medline, Embase, and PsychINFO) to be examined systematically. Studies with patients formally diagnosed by the International Classification of Diseases or the Diagnostic and Statistical Manual of Mental Disorders which include assessment of self-reported psychiatric symptoms will be included. Publications will be reviewed by teams of independent researchers. Quality of studies will be assessed using the Cochrane Collaboration’s tool for assessing risk of bias. Outcomes cover symptom-focused or disease-specific outcomes, relapse, recovery-focused outcomes, global functioning, quality of life and acceptability of the intervention. Further data that will be extracted includes study characteristics, target population, intervention, and tracking characteristics. Data will be synthesised qualitatively, summarising findings of the systematic review. Randomised controlled trials (RCTs) will be considered for meta-analysis if data is found comparable in terms of mental illness, study design and outcomes. Cumulative evidence will be evaluated according to the Grading of Recommendations Assessment, Development and Evaluation framework. Trial registration: Trial registration number: PROSPERO CRD42022356176.
- Open Access
- 19 August 2023
- Published by Springer Nature in European Archives of Psychiatry and Clinical Neuroscience
- Vol. 274 (4) , 827-835
Influence of noninvasive brain stimulation on connectivity and local activation: a combined tDCS and fMRI study
The effect of transcranial direct current stimulation (tDCS) on neurobiological mechanisms underlying executive function in the human brain remains elusive. This study aims at examining the effect of anodal and cathodal tDCS over the left dorsolateral prefrontal cortex (DLPFC) in comparison with sham stimulation on resting-state connectivity as well as functional activation and working memory performance. We hypothesized perturbed fronto-parietal resting-state connectivity during stimulation and altered working memory performance combined with modified functional working memory-related activation. We applied tDCS with 1 mA for 21 min over the DLPFC inside an fMRI scanner. During stimulation, resting-state fMRI was acquired and task-dependent fMRI during working memory task performance was acquired directly after stimulation. N = 36 healthy subjects were studied in a within-subject design with three different experimental conditions (anodal, cathodal and sham) in a double-blind design. Seed-based functional connectivity analyses and dynamic causal modeling were conducted for the resting-state fMRI data. We found a significant stimulation by region interaction in the seed-based ROI-to-ROI resting-state connectivity, but no effect on effective connectivity. We also did not find an effect of stimulation on task-dependent signal alterations in working memory activation in our regions of interest and no effect on working memory performance parameters. We found effects on measures of seed-based resting-state connectivity, while measures of effective connectivity and task-based connectivity did not show any stimulation effect. We could not replicate previous findings of tDCS stimulation effects on behavioral outcomes. We critically discuss possible methodological limitations and implications for future studies.
- 19 August 2023
- Published by Springer Nature in European Archives of Psychiatry and Clinical Neuroscience
- Vol. 274 (4) , 827-835
Open AccessInfluence of noninvasive brain stimulation on connectivity and local activation: a combined tDCS and fMRI study
The effect of transcranial direct current stimulation (tDCS) on neurobiological mechanisms underlying executive function in the human brain remains elusive. This study aims at examining the effect of anodal and cathodal tDCS over the left dorsolateral prefrontal cortex (DLPFC) in comparison with sham stimulation on resting-state connectivity as well as functional activation and working memory performance. We hypothesized perturbed fronto-parietal resting-state connectivity during stimulation and altered working memory performance combined with modified functional working memory-related activation. We applied tDCS with 1 mA for 21 min over the DLPFC inside an fMRI scanner. During stimulation, resting-state fMRI was acquired and task-dependent fMRI during working memory task performance was acquired directly after stimulation. N = 36 healthy subjects were studied in a within-subject design with three different experimental conditions (anodal, cathodal and sham) in a double-blind design. Seed-based functional connectivity analyses and dynamic causal modeling were conducted for the resting-state fMRI data. We found a significant stimulation by region interaction in the seed-based ROI-to-ROI resting-state connectivity, but no effect on effective connectivity. We also did not find an effect of stimulation on task-dependent signal alterations in working memory activation in our regions of interest and no effect on working memory performance parameters. We found effects on measures of seed-based resting-state connectivity, while measures of effective connectivity and task-based connectivity did not show any stimulation effect. We could not replicate previous findings of tDCS stimulation effects on behavioral outcomes. We critically discuss possible methodological limitations and implications for future studies.
- Open Access
- 24 August 2022
- Published by Springer Nature in European Archives of Psychiatry and Clinical Neuroscience
- Vol. 273 (5) , 1009-1022
Racism and psychosis: an umbrella review and qualitative analysis of the mental health consequences of racism
Black people and People of Color are disproportionately affected by racism and show increased rates of psychosis. To examine whether racialized migrant groups are particularly exposed to racism and therefore have higher risks for psychosis, this paper (1) systematically assesses rates of psychosis among racialized migrant groups concerning the country of origin, and (2) analyzes interviews regarding the association of racism experiences with psychosis-related symptoms in racialized Black people and People of Color populations in Germany. We present an umbrella review of meta-analyses that report the incidence of positive symptoms (e.g., hallucinations and delusions) and negative symptoms (e.g., apathy and incoherent speech) of diagnosed schizophrenia, other non-affective psychotic disorders (e.g., schizoaffective disorder) or first-episode psychosis among migrants by country of origin. We also report 20 interviews with first- and second-generation migrants racialized as Black and of Color in Germany to capture and classify their experiences of racism as well as racism-associated mental health challenges. In the umbrella review, psychosis risk was greatest when migration occurred from developing countries. Effect size estimates were even larger among Caribbean and African migrants. In the qualitative study, the application of the constant comparative method yielded four subordinate themes that form a subclinical psychosis symptomatology profile related to experiences of racism: (1) a sense of differentness, (2) negative self-awareness, (3) paranoid ideation regarding general persecution, and (4) self-questioning and self-esteem instability. We here provide converging evidence from a quantitative and qualitative analysis that the risk of poor mental health and psychotic experiences is related to racism associated with minority status and migration.
- 24 August 2022
- Published by Springer Nature in European Archives of Psychiatry and Clinical Neuroscience
- Vol. 273 (5) , 1009-1022
Open AccessRacism and psychosis: an umbrella review and qualitative analysis of the mental health consequences of racism
Black people and People of Color are disproportionately affected by racism and show increased rates of psychosis. To examine whether racialized migrant groups are particularly exposed to racism and therefore have higher risks for psychosis, this paper (1) systematically assesses rates of psychosis among racialized migrant groups concerning the country of origin, and (2) analyzes interviews regarding the association of racism experiences with psychosis-related symptoms in racialized Black people and People of Color populations in Germany. We present an umbrella review of meta-analyses that report the incidence of positive symptoms (e.g., hallucinations and delusions) and negative symptoms (e.g., apathy and incoherent speech) of diagnosed schizophrenia, other non-affective psychotic disorders (e.g., schizoaffective disorder) or first-episode psychosis among migrants by country of origin. We also report 20 interviews with first- and second-generation migrants racialized as Black and of Color in Germany to capture and classify their experiences of racism as well as racism-associated mental health challenges. In the umbrella review, psychosis risk was greatest when migration occurred from developing countries. Effect size estimates were even larger among Caribbean and African migrants. In the qualitative study, the application of the constant comparative method yielded four subordinate themes that form a subclinical psychosis symptomatology profile related to experiences of racism: (1) a sense of differentness, (2) negative self-awareness, (3) paranoid ideation regarding general persecution, and (4) self-questioning and self-esteem instability. We here provide converging evidence from a quantitative and qualitative analysis that the risk of poor mental health and psychotic experiences is related to racism associated with minority status and migration.
- 1 January 2022
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 94, 89-95
Nucleus basalis of Meynert predicts cognition after deep brain stimulation in Parkinson's disease
- 1 January 2022
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 94, 89-95
Nucleus basalis of Meynert predicts cognition after deep brain stimulation in Parkinson's disease
- 1 July 2021
- Published by Elsevier in Current Biology
- Vol. 31 (13) , 2868-2880.e8
An active role of inferior frontal cortex in conscious experience
- 1 July 2021
- Published by Elsevier in Current Biology
- Vol. 31 (13) , 2868-2880.e8
An active role of inferior frontal cortex in conscious experience